══════════════════════════════
Since 2014, my markets approach is to spot
trading opportunities based solely on the
development of
CLASSICAL CHART PATTERNS
🤝Let’s learn and grow together 🤝
══════════════════════════════
Hello Traders ✌
After a careful consideration I came to the conclusion that:
- it is crucial to be quick in alerting you with all the...
* Good earnings in the recent quarters
* Good up trend in the recent 2 years
* High 3-month RS of 34.4 in the Healthcare sector and a RS of 4.0 against the SP500
* UD Ratio of 1.57 meaning it's under accumulation
* Has been holding the earnings gap really well during this time
* Trading well above the 50 day avg volume
Trade Idea:
* You can enter now as this is...
I like the consolidation near the 3 month POC line and also the recent test and bounce off the 50MA. Additionally the 9ema crossed the 20 ema and it appears that the short to mid term trend is intact.
Also the candle closing above the .61 fib level and the upcoming MACD cross lead me to believe that this will break out.
Target: $14, $15.62
NASDAQ:INVA
Friends, another paper for trading on Monday.
What's on the chart:
1. A strong daily level formed by the hai of the paranormal bar from March 30.
2. Distant retest of the level
3. a 12.3% no-holds-barred rally.
Scenario:
Entry into the short at the breakdown of the level of 12.86
Important: we constantly write about the need to use stop...
Inva has activist Alex Denner in control of the board(5/5) and management which has been cut down to 2 people, includes CEO who is also Sarissa Executive. GSK has 30% ownership and probably will be likely buyer, they must have been waiting on Asthma indication approval which came earlier this month.
